Check Before You Invest : Nureca Ltd

Snapshot

Q.1 Which industry/sub-sector does Nureca Ltd belong to?

Nureca Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.

Q.2 Is Nureca Ltd a good quality company?

Nureca Ltd is a average quality company, based on a somewhat consistent 8-year financial track record.

Q.3 Is Nureca Ltd undervalued or overvalued?

Nureca Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Nureca Ltd a good buy now?

Nureca Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Nureca Ltd?

Nureca Ltd revenue growth is 21.3% for FY-2025, which is above its 5-year CAGR of 2.89%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Nureca Ltd?

Nureca Ltd Return on capital employed is 0.34% for FY-2025, which is in line with its 5-year historical median of 0.34%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Nureca Ltd?

Nureca Ltd Return on Asset is -0.33%, which is in line with its 5-year historical median of -0.33%, indicating stable asset utilization efficiency.

Q.4 Return on Equity (ROE) of Nureca Ltd?

Nureca Ltd Return on equity is -0.35% for FY-2025, which is in line with its 5-year historical median of -0.35%, indicating the business is making similar use of its shareholders capital.

Q.5 Cash conversion cycle of Nureca Ltd?

Nureca Ltd Cash conversion cycle is 86 days, in line with its 5-year historical median of 86 days, indicating stable working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.63	0.63
ROE	-0.35	-0.35
ROCE	0.34	0.34
Cash Conversion Cycle	86 days	86 days

Q.6 Gross Profit margin of Nureca Ltd?

Nureca Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.3% for FY-2025, which is in line with its 5-year median of 1.3%, indicating stable margins.

Q.7 Operating Profit Margin of Nureca Ltd?

Nureca Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -8.49% for FY-2025, which is in line with its 5-year median of -8.49% indicating stable margins.

Q.8 Net Profit Margin of Nureca Ltd?

Nureca Ltd Net Profit Margin is -0.58% for FY-2025, is in line with with its 5-year median of -0.58%, indicating stable margins.

	Current Level	5-year Historic Median
Gross Profit Margin	1.3	1.3
Operating Profit Margin	-8.49	-8.49
Net Profit Margin	-0.58	-0.58

Q.9 Debt to Equity ratio of Nureca Ltd?

Nureca Ltd Debt-to-Equity ratio is 0.01, which is lower with the industry average of 0.36, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Nureca Ltd?

Nureca Ltd Debt to cash flow from operations is -0.08, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Nureca Ltd?

Promoters hold 68.09% of the Nureca Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Nureca Ltd vs industry peers?

Nureca Ltd revenue CAGR is 2.89%, compared to the industry median CAGR of 13.8%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	21.3	13.8
Gross Profit Growth	0	28.3
Operating Profit Growth	0	17.4
Net Profit Growth	0	29.2

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.63	0.73
ROE	-0.35	15.79
ROCE	0.34	20.14
Cash Conversion Cycle (days)	86.02	89

Valuation & price assessment

Q.1 Stock return of Nureca Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -26.33% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-26.3%	-7.7%	16%

Q.3 Valuation ratios of Nureca Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	28.15	33.99	33.40
Price to Book	1.37	1.77	3.47
Price to Sales	1.76	3.20	3.50
EV to EBITDA	18.36	19.66	19.31

Check more companies

2. Laxmi Denta

6. Hemant Surgical Inds

7. Yash Optics & Lens

8. Nureca Ltd.

9. Earkart

10. Raaj Medisafe India

Check trending companies

1. Vardhman Textiles Ltd.

2. Tata Elxsi Ltd.

3. Shree Cement Ltd.

4. Amara Raja Energy & Mobility Ltd.

5. Vishal Mega Mart Ltd.